Laman UtamaSHTDY • OTCMKTS
add
Sinopharm Group ADR
Tutup sebelumnya
$13.26
Julat hari
$13.28 - $13.44
Julat tahun
$10.72 - $14.87
Permodalan pasaran
65.28B HKD
Bilangan Purata
77.78K
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 143.69B | 1.13% |
Perbelanjaan pengendalian | 5.00B | -10.42% |
Pendapatan bersih | 1.85B | 4.36% |
Margin untung bersih | 1.29 | 3.20% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 5.97B | -2.51% |
Kadar cukai berkesan | 30.30% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 48.80B | -10.16% |
Jumlah aset | 390.36B | -0.63% |
Jumlah liabiliti | 256.20B | -3.74% |
Jumlah ekuiti | 134.16B | — |
Syer tertunggak | 3.12B | — |
Harga kepada buku | 0.49 | — |
Pulangan pada aset | 3.34% | — |
Pulangan pada modal | 6.42% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.85B | 4.36% |
Tunai daripada operasi | 53.22B | -10.21% |
Tunai daripada pelaburan | -1.21B | 67.09% |
Tunai daripada pembiayaan | -30.23B | 18.95% |
Perubahan bersih dalam tunai | 21.77B | 19.12% |
Aliran tunai bebas | 24.05B | — |
Perihal
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Diasaskan
2003
Tapak web
Pekerja
94,910
